New research suggests that hydroxychloroquine works to reduce the risk of death by 30% in hospitalized patients. Confused? We don’t blame you

Stock Footage Inc/shutterstock.com
We have been caught in a drug war. This has nothing to do with cartels, turf battles or addictive chemicals. This is a war of words about hydroxychloroquine (HCQ), a really old malaria drug being repurposed to treat the coronavirus. When we first started writing about treatments for COVID-19 in March, we were intrigued by preliminary in vitro (test-tube) data. It appeared to us that hydroxychloroquine works by interfering with viral replication. That was the first hint that this medication might be helpful against SARS-CoV-2, the virus that causes COVID-19. Continue reading